Research & Development In Brief: PPIs and B12 deficiency, multivitamins trim cataracts risk, vitamin E slows Alzheimer’s
This article was originally published in The Tan Sheet
Executive Summary
Heartburn medicines raise B12 deficiency risk; multivitamins reduce cataracts risk; fat-soluble vitamin E slows Alzheimer’s; and modified acetaminophen overdose treatment reduces adverse events.
You may also be interested in...
Extra Strength Tylenol Cap Warning Prompts Label Reading
Beginning in October, bottle caps of Extra Strength Tylenol will warn consumers the product contains acetaminophen and they should always read the label. The warning is the third element to highlight the ingredient on Extra Strength Tylenol but the redundancy may be necessary because consumers do not read labels.
J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.
Ensuring Leading Position For GSK Consumer Products Touted In Management Shift
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.